日期:
2020 年 — 2026 年
2020
2021
2022
2023
2024
2025
2026
影响因子:

GD2-Targeted Minibody-Drug Conjugates Match the Potency of IgG-Based ADCs in a Mouse Cancer Model

在小鼠癌症模型中,GD2靶向微型抗体药物偶联物与基于IgG的抗体药物偶联物效力相当

Kalinovsky, Daniel V; Titov, Matvey M; Kholodenko, Irina V; Kibardin, Alexey V; Svirshchevskaya, Elena V; Deyev, Sergey M; Kholodenko, Roman V

Phase II Trial of Vemurafenib and Sorafenib Combination in Advanced KRAS-Mutated Metastatic Pancreatic Cancer

维莫非尼联合索拉非尼治疗KRAS突变晚期转移性胰腺癌的II期临床试验

Khawaja, Muhammad Rizwan; Jameson, Gayle; Cridebring, Derek; Shannon, Patricia; Han, Haiyong; Moore, Jaeger; Von Hoff, Daniel; Posner, Richard G; Hlavacek, William S; Kolch, Walter; Kholodenko, Boris N; Rukhlenko, Oleksii S; Roe, Denise J; Wertheim, Betsy C; Borazanci, Erkut

cSTAR analysis identifies endothelial cell cycle as a key regulator of flow-dependent artery remodeling

cSTAR 分析确定内皮细胞周期是血流依赖性动脉重塑的关键调节剂

Hanqiang Deng, Oleksii S Rukhlenko, Divyesh Joshi, Xiaoyue Hu, Philipp Junk, Anna Tuliakova, Boris N Kholodenko, Martin A Schwartz

Lipid peroxidation and type I interferon coupling fuels pathogenic macrophage activation causing tuberculosis susceptibility

脂质过氧化和I型干扰素偶联促进致病性巨噬细胞活化,导致结核病易感性。

Shivraj M Yabaji ,Vadim Zhernovkov ,Prasanna Babu Araveti ,Suruchi Lata ,Oleksii S Rukhlenko ,Salam Al Abdullatif ,Arthur Vanvalkenburg ,Yuriy O Alekseyev ,Qicheng Ma ,Gargi Dayama ,Nelson C Lau ,W Evan Johnson ,William R Bishai ,Nicholas A Crossland ,Joshua D Campbell ,Boris N Kholodenko ,Alexander A Gimelbrant ,Lester Kobzik ,Igor Kramnik

Transcriptome-Wide Analysis of Pituitary and Ectopic Adrenocorticotropic Hormone-Secreting Tumors

垂体和异位促肾上腺皮质激素分泌肿瘤的转录组分析

Buzdin, Anton A; Heydarov, Rustam N; Golounina, Olga O; Suntsova, Maria V; Matrosova, Alina V; Bondarenko, Ekaterina V; Roumiantsev, Sergey A; Sorokin, Maksim I; Kholodenko, Roman V; Kholodenko, Irina V; Chekhonin, Vladimir P; Plaksina, Evgeniya V; Rozhinskaya, Liudmila Y; Melnichenko, Galina A; Belaya, Zhanna E

Contrasting Impacts of Targeted Disruption of the Cancer Stem Cell Marker CD133 and Its Epigenetic Regulator TRIM28 in Colorectal Cancer Cells

靶向破坏癌症干细胞标志物 CD133 及其表观遗传调控因子 TRIM28 对结直肠癌细胞的影响截然不同

Irina V Kholodenko ,Aleena A Saidova ,Daria M Potashnikova ,Viktoriia A Arzumanian ,Daniil D Romashin ,Anna V Tvorogova ,Ekaterina V Poverennaya ,Konstantin N Yarygin ,Yan S Kim

A structure-based modelling approach identifies effective drug combinations for RAS-mutant acute myeloid leukemia.

基于结构的建模方法可确定 RAS 突变型急性髓系白血病的有效药物组合

Jones Luke, Rukhlenko Oleksii, Dias Tânia, Imoto Hiroaki, Carmody Ciardha, Wynne Kieran, Kholodenko Boris N, Bond Jonathan

Cell-specific models reveal conformation-specific RAF inhibitor combinations that synergistically inhibit ERK signaling in pancreatic cancer cells

细胞特异性模型揭示构象特异性 RAF 抑制剂组合可协同抑制胰腺癌细胞中的 ERK 信号传导

Thomas Sevrin, Hiroaki Imoto, Sarah Robertson, Nora Rauch, Uscinnia Dyn'ko, Katerina Koubova, Kieran Wynne, Walter Kolch, Oleksii S Rukhlenko, Boris N Kholodenko

Cell State Transition Models Stratify Breast Cancer Cell Phenotypes and Reveal New Therapeutic Targets

细胞状态转变模型对乳腺癌细胞表型进行分层,并揭示新的治疗靶点

Rukhlenko, Oleksii S; Imoto, Hiroaki; Tambde, Ayush; McGillycuddy, Amy; Junk, Philipp; Tuliakova, Anna; Kolch, Walter; Kholodenko, Boris N

Core-Shell Chitosan Particles Targeting Membrane-Bound Heat Shock Protein 70 for Cancer Therapy

用于癌症治疗的靶向膜结合热休克蛋白70的核壳壳聚糖颗粒

Svirshchevskaya, Elena V; Kostenko, Valentina V; Boyko, Anna A; Shevtsov, Maxim; Kholodenko, Roman V; Grechikhina, Maria V; Gracheva, Iuliia A; Fedorov, Alexey Yu; Sapozhnikov, Alexander M